{"nctId":"NCT00478192","briefTitle":"Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia","startDateStruct":{"date":"2007-04"},"conditions":["Hyponatremia"],"count":50,"armGroups":[{"label":"Regimen 1 Conivaptan QD","type":"EXPERIMENTAL","interventionNames":["Drug: Conivaptan"]},{"label":"Regimen 2 Conivaptan BID","type":"EXPERIMENTAL","interventionNames":["Drug: Conivaptan"]},{"label":"Regimen 3 Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Conivaptan","otherNames":["YM087","Vaprisol"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Euvolemic or hypervolemic (edematous) based on clinical presentation\n* Serum sodium between 115 and 130mEq/L at baseline\n\nExclusion Criteria:\n\n* Clinical presentation of volume depletion or dehydration","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Serum Sodium From Baseline to the 48 Hour Assessment or Study Drug Discontinuation.","description":"Baseline is the average of the two most recent serum sodium levels prior to start of dosing on day 1.\n\nHour 48: Hour 48 or time that ended study participation prior to the hour 48 assessment.\n\nChange is calculated as Hour 48 - Baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"126.03","spread":"4.017"},{"groupId":"OG001","value":"126.39","spread":"3.581"},{"groupId":"OG002","value":"125.55","spread":"3.648"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130.4","spread":"5.21"},{"groupId":"OG001","value":"133.4","spread":"4.82"},{"groupId":"OG002","value":"127.6","spread":"2.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.00","spread":"3.80"},{"groupId":"OG001","value":"7.36","spread":"4.04"},{"groupId":"OG002","value":"1.16","spread":"2.86"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Serum Sodium Level at Each Time Point Through the 48 Hour Assessment","description":"Baseline is the average of the two most recent serum sodium levels prior to start of dosing on day 1.\n\nHour 48: Hour 48 or time that ended study participation prior to the hour 48 assessment.\n\nChange is calculated as Actual Data for each time point - Baseline","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"126.03","spread":"4.02"},{"groupId":"OG001","value":"126.39","spread":"3.58"},{"groupId":"OG002","value":"125.55","spread":"3.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"128.03","spread":"4.62"},{"groupId":"OG001","value":"128.47","spread":"4.21"},{"groupId":"OG002","value":"125.80","spread":"4.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.59","spread":"2.32"},{"groupId":"OG001","value":"2.08","spread":"2.65"},{"groupId":"OG002","value":"-0.63","spread":"2.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"128.22","spread":"5.27"},{"groupId":"OG001","value":"130.85","spread":"5.88"},{"groupId":"OG002","value":"127.21","spread":"5.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.78","spread":"3.44"},{"groupId":"OG001","value":"4.65","spread":"4.06"},{"groupId":"OG002","value":"0.73","spread":"3.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"129.34","spread":"4.51"},{"groupId":"OG001","value":"131.04","spread":"5.07"},{"groupId":"OG002","value":"127.57","spread":"3.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.90","spread":"3.46"},{"groupId":"OG001","value":"4.93","spread":"3.28"},{"groupId":"OG002","value":"1.09","spread":"2.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"128.87","spread":"4.73"},{"groupId":"OG001","value":"130.74","spread":"5.33"},{"groupId":"OG002","value":"127.48","spread":"3.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.66","spread":"3.76"},{"groupId":"OG001","value":"4.62","spread":"3.59"},{"groupId":"OG002","value":"1.05","spread":"2.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130.79","spread":"4.94"},{"groupId":"OG001","value":"131.62","spread":"4.52"},{"groupId":"OG002","value":"126.49","spread":"4.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.35","spread":"3.80"},{"groupId":"OG001","value":"5.51","spread":"2.75"},{"groupId":"OG002","value":"0.06","spread":"3.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"131.42","spread":"4.99"},{"groupId":"OG001","value":"132.47","spread":"5.04"},{"groupId":"OG002","value":"127.31","spread":"3.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.98","spread":"3.73"},{"groupId":"OG001","value":"6.54","spread":"3.28"},{"groupId":"OG002","value":"0.89","spread":"2.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130.83","spread":"5.04"},{"groupId":"OG001","value":"132.23","spread":"3.99"},{"groupId":"OG002","value":"127.00","spread":"1.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.39","spread":"3.44"},{"groupId":"OG001","value":"6.30","spread":"3.27"},{"groupId":"OG002","value":"0.58","spread":"1.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130.44","spread":"5.21"},{"groupId":"OG001","value":"133.35","spread":"4.82"},{"groupId":"OG002","value":"127.59","spread":"2.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.00","spread":"3.80"},{"groupId":"OG001","value":"7.36","spread":"4.04"},{"groupId":"OG002","value":"1.16","spread":"2.86"}]}]}]},{"type":"SECONDARY","title":"Time From the First Dose of Study Medication to a Confirmed >4 mEq/L Increase From Baseline in Serum Sodium","description":"Confirmed sodium levels refers to two consecutive increases from baseline in sodium of \\>4 mEq/L; baseline is the average of the two most recent serum sodium levels prior to start of dosing on day 1.\n\nThe endpoint was not evaluable in the placebo arm (median and interquartile range cannot be estimated) or the conivaptan QD arm (interquartile range cannot be estimated) because too high a percentage of patients were censored for the event. Only the conivaptan BID arm will be reported.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.43","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Confirmed Serum Sodium Level > 4 mEq/L Increase From Baseline Over 0 to 48 Hours","description":"Confirmed sodium levels refers to two consecutive increases from baseline in sodium of \\>4 mEq/L; baseline is the average of the two most recent serum sodium levels prior to start of dosing on day 1.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"17","spread":null},{"groupId":"OG002","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Confirmed Serum Sodium Level Increase >6 mEq/L From Baseline or Confirmed Normal Serum Sodium Level (>135 mEq/L) Over the Duration 0 to 48 Hours","description":"Confirmed sodium levels refers to two consecutive increases from baseline in sodium of \\>6 mEq/L or two consecutive measurements \\>135 mEq/L; baseline is the average of the two most recent serum sodium levels prior to start of dosing on day 1.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Baseline -Adjusted Area Under the Curve (AUC) in Serum Sodium Over the Duration 0 to 48 Hours","description":"Each individual subject's change from baseline serum sodium levels was used to calculate baseline adjusted area under the curve serum sodium levels for a duration of Time 0 to Time t in hours (labeled as AUC(Na)(0-t). The last available serum sodium level prior to dosing on Day 1 was used as baseline.\n\n\"t\"=48 Hours","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"142.72","spread":"132.94"},{"groupId":"OG001","value":"244.17","spread":"142.64"},{"groupId":"OG002","value":"23.21","spread":"91.49"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Effective Water Clearance (EWC) at Each Time Point Through the 48-hour Assessment","description":"Effective water clearence (EWC) was calculated as EWC=V(1-(Una+Uk)/(Pna+Pk)), where V is urine volume, Una is the urine sodium concentration, Uk is the urine potassium concentration, Pna is the serum/plasma sodium concentration, an Pk is the serum /plasma potassium concentration.\n\nBaseline is the average of the two most recent serum sodium levels prior to start of dosing on day 1.\n\nHour 48: Hour 48 or time that ended study participation prior to the hour 48 assessment.\n\nChange is calculated as Actual Data for each time point - Baseline","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.76","spread":"47.91"},{"groupId":"OG001","value":"39.86","spread":"245.23"},{"groupId":"OG002","value":"18.66","spread":"45.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"355.65","spread":"684.35"},{"groupId":"OG001","value":"405.21","spread":"744.88"},{"groupId":"OG002","value":"136.22","spread":"154.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"301.52","spread":"671.78"},{"groupId":"OG001","value":"365.35","spread":"699.96"},{"groupId":"OG002","value":"135.44","spread":"123.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-50.19","spread":"794.22"},{"groupId":"OG001","value":"-261.27","spread":"1009.24"},{"groupId":"OG002","value":"368.01","spread":"688.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-70.61","spread":"796.01"},{"groupId":"OG001","value":"-391.76","spread":"1206.39"},{"groupId":"OG002","value":"383.73","spread":"723.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.85","spread":"905.18"},{"groupId":"OG001","value":"12.66","spread":"743.24"},{"groupId":"OG002","value":"726.96","spread":"1013.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-91.07","spread":"912.66"},{"groupId":"OG001","value":"-89.12","spread":"805.36"},{"groupId":"OG002","value":"810.45","spread":"1079.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-77.37","spread":"1169.30"},{"groupId":"OG001","value":"-179.37","spread":"852.58"},{"groupId":"OG002","value":"569.09","spread":"1392.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80.23","spread":"1116.99"},{"groupId":"OG001","value":"-240.39","spread":"759.82"},{"groupId":"OG002","value":"690.98","spread":"2872.2"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Free Water Clearance (FWC) at Each Time Point Through the 48-hour Assessment","description":"Free water clearance (FWC) was calculated as FWC=V(1-Uosm/Posm), where V is urine volume, Uosm is the urine osmolality, Posm is the plasma sodium osmolality.\n\nBaseline is the average of the two most recent serum sodium levels prior to start of dosing on day 1.\n\nHour 48: Hour 48 or time that ended study participation prior to the hour 48 assessment.\n\nChange is calculated as Actual Data for each time point - Baseline","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-53.87","spread":"45.47"},{"groupId":"OG001","value":"6.55","spread":"165.07"},{"groupId":"OG002","value":"-34.90","spread":"74.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-972.29","spread":"1455.66"},{"groupId":"OG001","value":"-611.14","spread":"693.863"},{"groupId":"OG002","value":"-416.71","spread":"666.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-936.99","spread":"1618.46"},{"groupId":"OG001","value":"-513.33","spread":"566.72"},{"groupId":"OG002","value":"-420.75","spread":"747.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1243.39","spread":"2211.22"},{"groupId":"OG001","value":"-769.19","spread":"934.31"},{"groupId":"OG002","value":"-592.96","spread":"1050.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1313.98","spread":"2477.39"},{"groupId":"OG001","value":"-603.67","spread":"761.90"},{"groupId":"OG002","value":"-702.11","spread":"1117.92"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":20},"commonTop":["Anaemia","Constipation","Hypotension","Nausea","Urinary tract infection"]}}}